Compile Data Set for Download or QSAR
Found 119 Enz. Inhib. hit(s) with all data for assayid = 1 entry = 1184
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177831(US9120791, Example 50 | US9120791, Example 94 | US...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177875(US9120791, Example 101 | US9603854, 101)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177867(US9120791, Example 92 | US9603854, 92)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177902(US9120791, Example 135 | US9603854, 135)copy SMILEScopy InChI
Affinity DataIC50: 6nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177876(US9120791, Example 103 | US9603854, 103)copy SMILEScopy InChI
Affinity DataIC50: 6nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177869(US9120791, Example 95 | US9603854, 95)copy SMILEScopy InChI
Affinity DataIC50: 6nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177879(US9120791, Example 107 | US9603854, 107)copy SMILEScopy InChI
Affinity DataIC50: 7nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177877(US9120791, Example 104 | US9603854, 104)copy SMILEScopy InChI
Affinity DataIC50: 7nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177886(US9120791, Example 115 | US9603854, 115)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177866(US9120791, Example 91 | US9603854, 91)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177899(US9120791, Example 129 | US9603854, 129)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177890(US9120791, Example 119 | US9603854, 119)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177885(US9120791, Example 114 | US9603854, 114)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177883(US9120791, Example 112 | US9603854, 112)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177880(US9120791, Example 108 | US9603854, 108)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177898(US9120791, Example 128 | US9603854, 128)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177887(US9120791, Example 116 | US9603854, 116)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177878(US9120791, Example 105 | US9603854, 105)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177870(US9120791, Example 96 | US9603854, 96)copy SMILEScopy InChI
Affinity DataIC50: 11nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177872(US9120791, Example 98 | US9603854, 98)copy SMILEScopy InChI
Affinity DataIC50: 12nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM312142(N-(4-Hydroxyphenyl)-N-(1-methyl-1H-indol-5-yl)-3-{...)copy SMILEScopy InChI
Affinity DataIC50: 12nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM312098(N-(4-Hydroxyphenyl)-N-(1-methyl-1H-indol-5-yl)-3-{...)copy SMILEScopy InChI
Affinity DataIC50: 12nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177840(US9120791, Example 59 | US9603854, 59)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177812(US9120791, Example 30 | US9603854, 30)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177829(US9120791, Example 48 | US9603854, 50)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177823(US9120791, Example 42 | US9603854, 42)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177793(US9120791, Example 9 | US9603854, 9)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177846(US9120791, Example 65 | US9603854, 65)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177805(US9120791, Example 23 | US9603854, 23)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177825(US9120791, Example 44 | US9603854, 44)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177817(US9120791, Example 35 | US9603854, 35)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177821(US9120791, Example 40 | US9603854, 40)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177791(US9120791, Example 6 | US9603854, 6)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177888(US9120791, Example 117 | US9603854, 117)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177792(US9120791, Example 8 | US9603854, 8)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177882(US9120791, Example 111 | US9603854, 111)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177889(US9120791, Example 118 | US9603854, 118)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177884(US9120791, Example 113 | US9603854, 113)copy SMILEScopy InChI
Affinity DataIC50: 16nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177892(US9120791, Example 122 | US9603854, 122)copy SMILEScopy InChI
Affinity DataIC50: 16nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177796(US9120791, Example 14 | US9603854, 14)copy SMILEScopy InChI
Affinity DataIC50: 16nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177833(US9120791, Example 52 | US9603854, 52)copy SMILEScopy InChI
Affinity DataIC50: 16nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177820(US9120791, Example 39 | US9603854, 39)copy SMILEScopy InChI
Affinity DataIC50: 16nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177847(US9120791, Example 66 | US9603854, 66)copy SMILEScopy InChI
Affinity DataIC50: 16nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177806(US9120791, Example 24 | US9603854, 24)copy SMILEScopy InChI
Affinity DataIC50: 17nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177797(US9120791, Example 15 | US9603854, 15)copy SMILEScopy InChI
Affinity DataIC50: 17nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177808(US9120791, Example 26 | US9603854, 26)copy SMILEScopy InChI
Affinity DataIC50: 17nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177809(US9120791, Example 27 | US9603854, 27)copy SMILEScopy InChI
Affinity DataIC50: 17nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177854(US9120791, Example 76 | US9603854, 76)copy SMILEScopy InChI
Affinity DataIC50: 17nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177786(US9120791, Example 1 | US9120791, Example 38 | US9...)copy SMILEScopy InChI
Affinity DataIC50: 18nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD

US Patent
LigandPNGBDBM177794(US9120791, Example 10 | US9120791, Example 37 | US...)copy SMILEScopy InChI
Affinity DataIC50: 18nMAssay Description:The fluorescence polarisation tests were carried out on microplates (384 wells). The Bcl-2 protein, at a final concentration of 2.50×10−8 M, is...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2GX4DMTUS Patent
Displayed 1 to 50 (of 119 total ) | Next | Last >>
Jump to: